Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang United Investment Group is a comprehensive financial group operating as an investment holding company, private equity, and venture capital firm. It manages over 35 venture and industry funds with total assets exceeding $2.8 billion USD. While not a direct biotech/pharma operator, ZUIG actively invests in the healthcare sector, including pharmaceuticals (e.g., Drug Farm for HBV, cancer, autoimmune therapies), medical devices (e.g., Robocath for cardiovascular robotics), IVD, precision medicine, and medical instruments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang United Investment Group.